Clinical Trial Update: A Study of S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of S-1 in combination with gemcitabine as first-line therapy for advanced biliary tract cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: TTY Biopharm | Conditions: Advanced Biliary Tract Cancer(BTC) | Phase 2 | Status: COMPLETED